Academic encounters in SAF The Faculty of Medicine delivers world-leading academic research and teaching embedded within the distinctive scientific focus of Imperial College London.  Our programmes draw on the talent of the entire university to bridge the gap between disciplines and pull through discoveries from across the science base to help identify the causes of ill-health, treat disease and improve wellbeing.

Beyond the borders of Imperial our faculty collaborate widely with major academic partners. We work with colleagues across the UK science base as part of an outstanding national environment for biomedical discovery and translation.  At an international level, we have built innovative organisational relationships, major country-to-country programmes, and highly successful regional and global collaborations.  

Our London location allows us to work with field leaders at major academic institutions and key global organisations.  Our campuses are all close to the capital's excellent national, european and international transport links - enabling us to welcome our international partners to collaborate with us at our campuses, and our staff to engage with colleagues around the world.

Collaborating with our academic partners

Our partner faculties

Our academic programmes within the College are strengthened through wide-ranging collaborations, and supported by intramural research hubs that unite a broad range of Imperial disciplines to tackle areas of health need in new ways.

Some examples of our multidisciplinary working include:

  • the Medical Research Council (MRC) London Institute of Medical Sciences (LMS) is a direct-funded institute of the MRC.  It forms the larger part of Imperial's 'Institute of Clinical Sciences', one of the Faculty's five academic departments. Investigators at the Centre work closely with colleagues across the University.
  • The Antimicrobial Research Collaborative at Imperial (ARC@Imperial) - this pan-Faculty collaborative consolidates world leading, multidisciplinary research across the College to address the urgent global threat of antimicrobial resistance from a 'one health' perspective.
  • the Institute of Biomedical Engineering (IBME) Research Technology Networks which draw together researchers from across Imperial to promote and coordinate multi-disciplinary research programmes for generation of novel IP in specific therapeutic/disease management areas that will benefit patients.
  • the Centre for Health Policy which brings together academics from across the College to catalyse the development, uptake and diffusion of innovation, patient safety, e-health and informatics, behavioural economics and quality of care through effective health policy.

The work of individual collaborative centres such as these brings academic activity together at a grass-roots level. This is complemented by the College's establishment of a number of institutional level inter-Faculty Global Challenge Institutes, which include the Institute for Global Health Innovation and the Data Sciences Institute. All of these centres and Institutes share a common mission to bring academics together in new ways and to support them in creating outstanding discovery science, novel courses and curricula, and tangible impact and benefit.

Read more about the many Faculty and multi-disciplinary research groups  and units in which our Faculty is a partner.

UK partnering

At Imperial, we are proud to work with outstanding university, funding and policy partners across a broad range of health and related disciplines. Our academics collaborate and publish widely as part of multi-institutional research studies, and have developed a number of innovative, inter-institutional education and training programmes. Examples of the strong and diverse UK academic partnerships in which we engage include:

  • the Cancer Research Centre of Excellence (CRCE) was announced in 2016.  The Centre will see academics and clinicians at the College and the Institute of Cancer Research (ICR) working together to deliver a world-leading programme of cancer research – paving the way for new therapies and interventions.
  • the MRC-NIHR National Phenome Centre  - led by Imperial College London and King's College London, this MRC and NIHR funded centre delivers broad access to world-class capability in metabolic phenotyping for the whole UK translational medicine community. The establishment of the Centre enables the UK to take best advantage of the legacy of the 2012 Olympics state-of-the-art drug testing/analytical laboratory. The Centre's work is also supported by significant contributions of staff, equipment and technical support from major instrument suppliers of both MS (The Waters Corporation) and NMR (Bruker Biospin GmbH). Both companies work with the Centre to develop the technology and establish a major training centre - the International Phenome Training Centre.
  • the Health Sciences Academy (HSA) - a one-stop-shop for comprehensive, high-quality courses to meet the postgraduate training and education needs of healthcare professionals in North West London, the UK and worldwide. The HSA is a joint enterprise between Imperial, Brunel University London and Buckinghamshire New University. Originally conceived by Imperial, this partnership brings together the complementary strengths of the three universities to offer high-quality courses that are responsive to national education and training priorities with the overall aim of enhancing patient care. Course content is informed by world-leading research in the partner universities and designed to fit flexibly alongside professional commitments.
  • the Francis Crick Institute (FCI) - along with academic colleagues across the College, the Faculty of Medicine is engaging alongside the other partner HEIs (King's College London and University College London), Cancer Research UK, the MRC and the Wellcome Trust to develop strong translational pathways and programmes within this world-leading new Institute, aiming to deliver major clinical benefits from its discovery science. Find out more about Imperial and the Crick on our main College pages.


 Our Faculty contribute broadly to international healthcare developments with a broad range of partners. Our international engagement spans high level policy development, global health trend monitoring, international clinical trials, international consultancy and collaborative establishment of new science-led health research and education institutions.

A major recent international development for the Faculty has been the launch of the Lee Kong Chian School of Medicine, a joint initiative between Imperial College London and Nanyang Technological University in Singapore. Read on about this important new collaborative education development in our sample selection of Faculty collaborations.

Further exemplars of our engagement include:

  • the Wellcome Centre for Global Health Research - which aims to contribute to the understanding, and effective prevention and treatment of the major health problems of low- and middle- income countries (LMICs), through partnerships with academic institutions in Africa, Asia, and Latin America, and support the training and career development of local clinicians and nonclinical scientists through a programme of mentorship, capacity building, and knowledge transfer.
  • the Imperial College London Diabetes Centre - a successful initiative located at two centres in the United Arab Emirates. The Centre provides a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness. ICLDC has treated nearly 300,000 people since its launch in late 2006, with another 175,000-plus engaged by the nationwide public health outreach.
  • the World Health Organisation (WHO) Collaborating Centre for Public Health Education and Training - hosted at Imperial, the Centre works broadly to develop research and training to encourage academic exchange and build capacity in the area of public health and primary care. This includes advising on evaluation of health systems, support for development and application of systems of standards and accreditation of healthcare services, education and training, service quality and patient safety, and strengthening family practice service delivery.
  • the MRC Centre for Outbreak Analysis and Modelling - an international resource and centre of excellence for research on the epidemiological analysis and modelling of infectious disease outbreaks. It has built a world-leading group of epidemiological researchers to support policy planning and response operations against emerging and endemic infectious disease threats. The Centre advises governments and international agencies on the control of a wide range of diseases and has established long-term collaborative partnerships with national and international health foundations and public health agencies including Public Health England (PHE), WHO, the US Centers for Disease Control (CDC) and the Bill and Melinda Gates Foundation.

At an institutional level, international engagement is supported by the establishment of the cross-Faculty Institute of Global Health Innovation which works to support the identification, development and widespread diffusion of healthcare innovation, and in doing so to sustainably reduce inequalities in global healthcare.